Chemicals and Drugs

Daclizumab

An anti-TAC (INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT) humanized monoclonal antibody (immunoglobulin G1 disulfide with human-mouse monoclonal clone 1H4 light chain, dimer) that is used in the treatment of ACUTE RELAPSING MULTIPLE SCLEROSIS.

National Library of MedicineMedical Subject Headings2026

Structured Summary

Abstract

An anti-TAC (INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT) humanized monoclonal antibody (immunoglobulin G1 disulfide with human-mouse monoclonal clone 1H4 light chain, dimer) that is used in the treatment of ACUTE RELAPSING MULTIPLE SCLEROSIS.

MeSH Record

Classification

Broader headings

Related Concepts

Knowledge Graph

Loading graph…

Drag nodes to rearrange; hover to trace links; click a node to open its page.

Drug Class

Pharmacological Action

MeSH Record

Synonyms

7 entry terms
  • Dacliximab
  • Ro 24-7375
  • Ro-24-7375
  • Zenapax
  • Zinbryta
  • Ro 24 7375
  • Ro 247375

MeSH Record

Aspects Covered

24 allowable subheadings

Indexed with the subheadings administration & dosage, adverse effects, analysis, biosynthesis, blood, cerebrospinal fluid, chemistry, classification, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, therapeutic use, toxicity, ultrastructure, urine.

MeSH Record

History Note

2019 (1995)

MeSH Hierarchy

Tree Numbers

  1. D12.776w.124w.486.485.114w.224w.060w.766w
  2. D12.776w.124w.790.651.114w.224w.060w.766w
  3. D12.776w.377w.715.548.114w.224w.200w.766w

AMA Style

References

  1. National Library of Medicine. Daclizumab. Medical Subject Headings (MeSH). 2026. Unique ID D000077561. http://id.nlm.nih.gov/mesh/2026/D000077561
  2. Daclizumab. In: Wikipedia. https://en.wikipedia.org/wiki/Daclizumab
  3. Daclizumab. In: Wikidata. https://www.wikidata.org/wiki/Q412920